Groundbreaking Clinical Trial Shows Durvalumab Plus Ceralasertib Enhances Immune Response in Lung Cancer Patients
A recent clinical trial conducted by researchers at The University of Texas MD Anderson Cancer Center has found that a specific combination of targeted therapy …